Pharma Lobby Wants Some Patents Exempt From AIA Review
Pharmaceutical industry lobbyists called on lawmakers Wednesday to exempt certain biopharmaceutical patents from challenge in America Invents Act reviews, contending that not doing so could hamper the development of new medicines....To view the full article, register now.
Already a subscriber? Click here to view full article